Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Limited is an India-based pharmaceutical company. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Company's products include Amphetamine Sulfate Tablets USP, 5 mg and 10 mg; Hydroxychloroquine Sulfate Tablets USP, 200 mg; Ketoconazole Tablets USP, 200 mg; Chlorzoxazone Tablets USP, 250 mg; 5Chlorzoxazone Tablets USP, 500 mg; Ketorolac Tromethamine Tablets USP, 10 mg; Diclofenac Potassium Tablets USP, 25 mg; Diclofenac Potassium Tablets USP, 50 mg, and others. It supplies affordable APIs to generic formulations manufacturers. Its product API include Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, and others. Its domestic portfolio includes Azithromycin for Injection; Meropenem Injection; Ferric Carboxymaltose Injection; Meropenem and Sulbactam for Injection, and others.
Senores Pharmaceuticals Ltd FAQs
How to Buy Senores Pharmaceuticals Ltd Share?
To purchase Senores Pharmaceuticals Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Senores Pharmaceuticals Ltd (ticker symbol: SENORES) on the trading platform provided by your broker and purchase the shares.
The stock price of Senores Pharmaceuticals Ltd as of 03 Oct 2025 is ₹666.95
What is the Market Cap of Senores Pharmaceuticals Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 03 Oct 2025, Senores Pharmaceuticals Ltd (ticker symbol: SENORES) has a market capitalisation of approximately ₹31,00,00,00,000.00
What is the PE and PB ratio of Senores Pharmaceuticals Ltd?
Senores Pharmaceuticals Ltd Ltd's price-to-book ratio as of 03 Oct 2025 is 3.91, reflecting the market's valuation compared to its asset value. As of 03 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 52.43, indicating the market values the company at around ₹52.43 for every ₹1 of earnings
What is the 52 Week High and Low of Senores Pharmaceuticals Ltd Share?
Senores Pharmaceuticals Ltd Ltd (SENORES) hit its 52-week high at ₹746.99, and its 52-week low at ₹435.25.